AAREY DRUGS & PHARM LTD

AAREYDRUGS

Small Cap | Pharmaceuticals
67.18
+1.57 (+2.39%)

Stock price as on 06 Feb 2026 at 15:30 PM

Aarey drugs & pharm ltd share price update

As of the latest trading session, Aarey Drugs & Pharm Ltd share price is currently at ₹67.18, which is up by ₹1.57 from its previous closing. Today th...

Aarey Drugs & Pharm Ltd stock performance

Today’s low

₹62.41

Today’s high

₹67.7

₹67.18

52 week low

₹31.35

52 week high

₹100

₹67.18
Open
₹66.48
Previous close
₹65.61
Share volume
1,13,962
Total traded value (Lakh)
₹76.55
Upper circuit
₹72.17
Lower circuit
₹59.05

Aarey Drugs & Pharm Ltd fundamentals

Market cap (Cr)
₹190.50
P/E ratio (TTM)
52.4
Book value per share
₹51.13
Beta
0.89
Return on equity
2.96%
Earnings per share (TTM)
₹1.26
Dividend yield
0%
Net profit/quarter (Cr)
₹1.02

Aarey Drugs & Pharm Ltd financials

(Values in Cr)
Revenue
Net income

Particulars

Sep 25 (₹ value in crores)

Revenue

₹84.16

Operating expense

₹83.47

Net income

₹1.02

Net profit margin

1.21%

Earning per share

₹0.36

EBITDA

₹3.43

Effective tax rate

31.08%

Particulars

Jun 25 (₹ value in crores)

Revenue

₹102.21

Operating expense

₹102.03

Net income

₹1.37

Net profit margin

1.34%

Earning per share

₹0.48

EBITDA

₹3.26

Effective tax rate

20.8%

Particulars

Mar 25 (₹ value in crores)

Revenue

₹108.10

Operating expense

₹114.00

Net income

₹0.47

Net profit margin

0.43%

Earning per share

₹0.17

EBITDA

₹3.34

Effective tax rate

70.55%

Particulars

Dec 24 (₹ value in crores)

Revenue

₹133.79

Operating expense

₹133.07

Net income

₹0.72

Net profit margin

0.53%

Earning per share

₹0.26

EBITDA

₹2.88

Effective tax rate

48.57%

Particulars

Sep 24 (₹ value in crores)

Revenue

₹105.14

Operating expense

₹103.42

Net income

₹1.60

Net profit margin

1.52%

Earning per share

₹0.57

EBITDA

₹3.75

Effective tax rate

8.57%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Revenue

₹473.94

Operating expense

₹477.65

Net income

₹4.02

Net profit margin

0.84%

Earning per share

₹1.43

EBITDA

₹12.70

Effective tax rate

34.09%

Particulars

Mar 24 (₹ value in crores)

Revenue

₹395.62

Operating expense

₹397.24

Net income

₹4.68

Net profit margin

1.18%

Earning per share

₹1.84

EBITDA

₹11.42

Effective tax rate

12.35%

Particulars

Mar 23 (₹ value in crores)

Revenue

₹418.96

Operating expense

₹415.67

Net income

₹3.78

Net profit margin

0.9%

Earning per share

₹1.49

EBITDA

₹10.46

Effective tax rate

37.2%

Particulars

Mar 22 (₹ value in crores)

Revenue

₹492.68

Operating expense

₹485.40

Net income

₹6.54

Net profit margin

1.32%

Earning per share

₹2.72

EBITDA

₹14.02

Effective tax rate

34.69%

Particulars

Mar 21 (₹ value in crores)

Revenue

₹348.42

Operating expense

₹347.13

Net income

₹6.51

Net profit margin

1.86%

Earning per share

₹2.79

EBITDA

₹11.65

Effective tax rate

21.56%

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 25 (₹ value in crores)

Book value per share

₹46.90

Return on Equity (ROE)

2.96%

Return on Capital Employed (ROCE)

6.38%

Total debt to equity ratio

0.24

EBITDA margin

2.68%

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

₹45.57

Return on Equity (ROE)

3.74%

Return on Capital Employed (ROCE)

6.09%

Total debt to equity ratio

0.28

EBITDA margin

2.89%

Particulars (annual)

Mar 23 (₹ value in crores)

Book value per share

₹44.43

Return on Equity (ROE)

3.26%

Return on Capital Employed (ROCE)

6.28%

Total debt to equity ratio

0.22

EBITDA margin

2.49%

Particulars (annual)

Mar 22 (₹ value in crores)

Book value per share

₹43.85

Return on Equity (ROE)

6.16%

Return on Capital Employed (ROCE)

9.79%

Total debt to equity ratio

0.15

EBITDA margin

2.86%

Particulars (annual)

Mar 21 (₹ value in crores)

Book value per share

₹41.29

Return on Equity (ROE)

6.81%

Return on Capital Employed (ROCE)

9.38%

Total debt to equity ratio

0.19

EBITDA margin

3.35%

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Cash and short term investments

₹1.47

Total assets

₹290.59

Total liabilities

₹290.59

Total equity

₹138.48

Shares outstanding

₹2.84

Price to book ratio

₹0.72

Return on assets (%)

1.38%

Return on capital

2.32%

Particulars

Mar 24 (₹ value in crores)

Cash and short term investments

₹1.59

Total assets

₹303.29

Total liabilities

₹303.29

Total equity

₹132.77

Shares outstanding

₹2.80

Price to book ratio

₹0.98

Return on assets (%)

1.54%

Return on capital

2.85%

Particulars

Mar 23 (₹ value in crores)

Cash and short term investments

₹0.70

Total assets

₹291.32

Total liabilities

₹291.32

Total equity

₹117.40

Shares outstanding

₹2.53

Price to book ratio

₹0.53

Return on assets (%)

1.29%

Return on capital

2.43%

Particulars

Mar 22 (₹ value in crores)

Cash and short term investments

₹0.19

Total assets

₹245.16

Total liabilities

₹245.16

Total equity

₹113.63

Shares outstanding

₹2.53

Price to book ratio

₹0.94

Return on assets (%)

2.67%

Return on capital

5.13%

Particulars

Mar 21 (₹ value in crores)

Cash and short term investments

₹0.64

Total assets

₹233.03

Total liabilities

₹233.03

Total equity

₹98.86

Shares outstanding

₹2.33

Price to book ratio

₹0.56

Return on assets (%)

2.79%

Return on capital

5.57%

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Net income

₹6.10

Cash from operations

₹12.20

Cash from investing

-₹5.93

Cash from financing

-₹4.48

Net change in cash

-₹0.12

Free cash flow

₹17.41

Particulars

Mar 24 (₹ value in crores)

Net income

₹5.34

Cash from operations

-₹1.66

Cash from investing

-₹1.70

Cash from financing

₹5.58

Net change in cash

₹0.88

Free cash flow

-₹0.94

Particulars

Mar 23 (₹ value in crores)

Net income

₹6.00

Cash from operations

₹0.99

Cash from investing

₹0.44

Cash from financing

₹1.35

Net change in cash

₹0.51

Free cash flow

₹2.04

Particulars

Mar 22 (₹ value in crores)

Net income

₹10.02

Cash from operations

₹4.08

Cash from investing

-₹3.21

Cash from financing

₹2.25

Net change in cash

-₹0.45

Free cash flow

₹6.29

Particulars

Mar 21 (₹ value in crores)

Net income

₹8.30

Cash from operations

₹7.14

Cash from investing

-₹2.87

Cash from financing

-₹2.45

Net change in cash

₹0.14

Free cash flow

₹10.02

Aarey Drugs & Pharm Ltd technical summary

₹67.18
+ 2.39 ▲
9
Bearish
7
Bullish
5 Day65.7
10 Day65.9
12 Day66
20 Day66.5
26 Day67.2
50 Day70.2
100 Day72.4
200 Day69.6
5 Day64.9
10 Day66.6
12 Day66.7
20 Day66
26 Day66.4
50 Day69.3
100 Day78.4
200 Day70

64.89

PIVOT

First support
₹62.99
First resistance
₹67.52
Second support
₹60.36
Second resistance
₹69.42
Third support
₹58.46
Third resistance
₹72.05
RSI
49.68
ADX
18.14
MACD
-1.19
Williams % R
-46.71
Commodity Channel Index (CCI)
-3.51
Date
06 Feb 2026
Same day
68,162
Week
73,543
Month
1,23,081
1 year
0.9
3 years
0.85
Over 1 month
0.7%
Over 1 year
39.31%
Over 3 months
-32.31%
Over 3 years
25.17%
Over 6 months
-1.89%
Over 6 years
9.15%

Investment Returns

Over 1 Month0.7%
Over 3 Months32.31%
Over 6 Months1.89%
Over 1 Year39.31%

Aarey Drugs & Pharm Ltd Shareholding pattern


Public
57.08%
Promoter holdings
39.05%
FII
3.85%
DII
0%
Promoter shares
0%
Promoter sharesShareCategory

Bina Rajesh Ghatalia

40,03,584 (14.12%)

Shareholding of Promoter and Promoter Group

Mihir Rajesh Ghatalia

28,35,888 (10%)

Shareholding of Promoter and Promoter Group

Nimit Impex

20,10,000 (7.09%)

Shareholding of Promoter and Promoter Group

Nimit Rajesh Ghatalia

11,50,000 (4.06%)

Shareholding of Promoter and Promoter Group

Elysian Wealth Fund

7,50,000 (2.65%)

Public Shareholding

Promoter sharesShareCategory
Bina Rajesh Ghatalia40,03,584 (14.12%)Shareholding of Promoter and Promoter Group
Mihir Rajesh Ghatalia28,35,888 (10%)Shareholding of Promoter and Promoter Group
Nimit Impex20,10,000 (7.09%)Shareholding of Promoter and Promoter Group
Nimit Rajesh Ghatalia11,50,000 (4.06%)Shareholding of Promoter and Promoter Group
Elysian Wealth Fund7,50,000 (2.65%)Public Shareholding
Mira Mihir Ghatalia6,90,000 (2.43%)Shareholding of Promoter and Promoter Group
Suvi Rubber Pvt Ltd6,00,000 (2.12%)Public Shareholding
Krishnamurthy C G5,00,000 (1.76%)Public Shareholding
Chetan Kiritbhai Mehta4,50,000 (1.59%)Public Shareholding
Nishith Atulbhai Shah4,02,473 (1.42%)Public Shareholding
Archana Pramod Wani4,00,000 (1.41%)Public Shareholding
Suraj Tradelinks3,81,336 (1.34%)Shareholding of Promoter and Promoter Group
Resonance Opportunities Fund2,99,000 (1.05%)Public Shareholding
Vijaykumar Babulal Shah2,94,950 (1.04%)Public Shareholding
Rajesh Pranlal Ghatalia2,971 (0.01%)Shareholding of Promoter and Promoter Group

About AAREY DRUGS & PHARM LTD

Aarey Drugs & Pharmaceuticals Limited was originally incorporated on May 15, 1990 as a private limited company in Mumbai with the name Niharika Textiles & Chemicals Private Limited. The company was originally promoted by Prakash Mandhana, Kavita Mandhana and Neeta Mandhana. In March, 1993, the Aarey Group of companies belonging to Ghatalia family took over the Company and it was converted into public limited company. Also, the name of the company was changed from Niharika Textiles & Chemicals Private Limited to Aarey Drugs & Pharmaceuticals Li

Parent Organisation

Indian Private

NSE Symbol

AAREYDRUGS

Founded

1990

AAREY DRUGS & PHARM LTD CORPORATE ACTION

Dividend dateDividend amountDividend typeRecord dateInstrument type
13 Dec 20180.1Interim14 Dec 2018Equity shares

View more stocks

What’s trending

All stocks

LOYALTEX

LOYAL TEXTILE MILLS LTD.

304.8
+50.8 (+20%)
GORANIN

GORANI INDUSTRIES LTD.

63.61
+10.6 (+20%)
NIRAJISPAT

NIRAJ ISPAT IND LTD

257.41
+42.9 (+20%)
STRATMONT

STRATMONT INDUSTRIES LIMITED

90.01
+15 (+20%)
View all

Top gainers

ITC

ITC LTD

325.8
+15.60 (+5.03%)
KOTAKBANK

KOTAK MAHINDRA BANK LTD

422.35
+13.60 (+3.33%)
HINDUNILVR

HINDUSTAN UNILEVER LTD.

2424.2
+69.80 (+2.96%)
BHARTIARTL

BHARTI AIRTEL LIMITED

2038.4
+46.00 (+2.31%)
View all

Top losers

HDFCLIFE

HDFC LIFE INS CO LTD

703.5
-17.20 (-2.39%)
TCS

TATA CONSULTANCY SERV LT

2941.6
-49.90 (-1.67%)
TECHM

TECH MAHINDRA LIMITED

1619.9
-26.30 (-1.60%)
BAJAJ-AUTO

BAJAJ AUTO LIMITED

9518.5
-128.50 (-1.33%)
View all

Frequently asked questions


Related videos


Related tags


You are here


Related links

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer


Powered by Bajaj Financial Securities Limited (Bajaj Broking)